Biggest News Aggregation in the World
📰 Rna News

Page 23 - Rna News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rna. Real-time updates on events, politics, business and more.

Analysts Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $38.83

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective […]
Charles Schwab Investment Management Inc Wells Fargo Company Avidity Biosciences Inc Avidity Biosciences Company Profile Metlife Investment Management Dimensional Fund Advisors

Avidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Rating of "Buy" by Brokerages

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned an average rating of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages […]
United States American International Group Inc Daiwa Securities Group Inc Group Plc Wells Fargo Company Ameritas Investment Partners Inc

cepi: CEPI to fund Gennova's self­ amplifying mRNA vaccine against Disease X

The Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop vaccine candidates against unknown pathogenic threats with the particular development of saRNA vaccines that use the bodys own machinery to make antigenic protein.
Gennova Biopharmaceuticals Ltd Coalition For Epidemic Preparedness Innovations Epidemic Preparedness Innovations Pune Based Gennova Biopharmaceuticals Ltd Gennova Vaccine

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

#VisualAbstract: A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute
Minute Medicine Inc Alanine Aminotransferase Alt Hepatitis D

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science